Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic
hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is …

The prevalence of diabetes is growing at epidemic rates in the USA. Diabetic retinopathy
develops in a large proportion of patients and is a leading cause of blindness worldwide …

Decades of research into the pathophysiology and management of diabetic retinopathy
have revolutionized our understanding of the disease process. Diabetic retinopathy is now …

Although current treatment and prevention of diabetic retinopathy with laser
photocoagulation, and tight metabolic and blood pressure control has reduced the risk of …

Diabetes mellitus has become a major health concern worldwide and its incidence is
projected to increase. Diabetic macular edema (DME) and proliferative diabetic retinopathy …

Over 135 million individuals are af-flicted with diabetes across the world. In the US, diabetes
affects over 18.2 million people (or 6.3% of the total population) and 800,000 new cases of …

Before the discovery of insulin, diabetes had been a fatal disease. Insulin extended lifespan
of diabetic patients, yet it also gave rise to a number of chronic vascular complications …

Diabetic retinopathy is a leading cause of visual loss in industrialized countries. Its
classification includes preclinical, nonproliferative (mild, moderate, and severe or …

For the past several decades, tremendous efforts have been made to decrease the
complications of diabetes, including diabetic retinopathy. New diagnostic modalities like …

It is well remembered that Canadians, Frederick Banting and John Mcleod, jointly received
the 1923 Nobel Prize in Medicine for the discovery of insulin, and that Eli Lilly, whose …